Skip to main content

endocarditis, natieve klep, rechtszijdig bij IV drugsgebruik - stafylokokken

Advices

≥ 18 years

Indications: Methicilline gevoelig

Priority Medication Remarks
Priority:
1st choice
Medication:

flucloxacilline iv 2000mg 6dd 2 weeks

≥ 18 years

Indications: Methicilline resistent

Priority Medication Remarks
Medication:

vancomycine iv 4 to 6 weeks

Remarks:

Dosering vancomycine  continu en intermitterend: zie opmerking en LINK.

General comments

Voor voorwaarden voor twee weekse behandeling zie de ESC guideline.

Methicilline gevoelig: Staphylococcus aureus = MSSA of coagulase-negatieve stafylokokken = MSSE; methicilline resistent: Staphylococcus aureus = MRSA of coagulase-negatieve stafylokokken = MRSE

Onderhoudsdosering vancomycine afhankelijk van gemeten spiegels en van nierfunctie, zie onder middelen in huidige formularium: https://jbzbnh.adult.nl.antibiotica.app/nl/node/499806

Sources

  1. Pubmed.gov publication # 26320109

    2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Antimicrobial resources

The following antimicrobial agents have been used in these recommendations:

External antimicrobial resources
Menu position
Metadata

Swab vid: G-196893.9
Updated: 04/19/2023 - 13:24
Status: Published